SCHEMBL13593311

SCHEMBL13593311

O=C(O)CCCc1ccc(NC(=O)c2cc3ccccc3cc2O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 3/20 0.67
KLK1 P06870 2/20 0.67
KLK6 Q92876 2/20 0.67
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
NPC1 O15118 4/20 0.60
RAB9A P51151 4/20 0.60
POLB P06746 3/20 0.60
CASP3 P42574 1/20 0.57
SENP7 Q9BQF6 1/20 0.57
SENP6 Q9GZR1 1/20 0.57
MAPT P10636 2/20 0.57
MAPK1 P28482 1/20 0.57
APOBEC3A P31941 1/20 0.57
APOBEC3G Q9HC16 1/20 0.57
CYP1A2 P05177 1/20 0.55
ALOX15 P16050 2/20 0.54
SAE1 Q9UBE0 1/20 0.54
UBA2 Q9UBT2 1/20 0.54
PLAU P00749 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13593315 0.92 PLG (0.70) PLGKLK1KLK6MEN1KMT2A
SCHEMBL11307013 0.88 PLG (0.79) PLGKLK1KLK6MEN1KMT2A
SCHEMBL11037380 0.86 PLG (0.68) PLGKLK1KLK6MEN1KMT2A
SCHEMBL6381563 0.84 ALOX15 (0.70) PLGMEN1KMT2ANPC1RAB9A
SCHEMBL12799119 0.83 PLG (0.71) PLGKLK1KLK6MEN1KMT2A
SCHEMBL5426499 0.82 KMT2A (0.84) PLGKLK1KLK6MEN1KMT2A
SCHEMBL13593291 0.81 PLG (0.67) PLGKLK1KLK6MEN1KMT2A
SCHEMBL14328955 0.81 PLG (0.77) PLGKLK1KLK6MEN1KMT2A
SCHEMBL30084384 0.81 MEN1 (0.77) PLGKLK1KLK6MEN1KMT2A
SCHEMBL29890853 0.81 MEN1 (0.77) PLGKLK1KLK6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324540-A1 COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2009-12-31 US disclosed
US-20090324540-A1 COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2009-12-31 US disclosed
US-7553872-B2 Compounds and compositions for delivering active agents EMISPHERE TECHNOLOGIES, INC. (US) 2009-06-30 US disclosed
US-7553872-B2 Compounds and compositions for delivering active agents EMISPHERE TECHNOLOGIES, INC. (US) 2009-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324540-A1 COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS ABCB4, ABCB7, ALPP PLG 83/4885KLK1 2818/4885KLK6 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.